PodParley PodParley
PodParley
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy episode artwork

EPISODE · May 16, 2025 · 37 MIN

Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

from Hematologic Oncology Update

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published May 16, 2025

Embed this episode

NOW PLAYING

Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

0:00 37:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Hematologic Oncology Update?

This episode is 37 minutes long.

When was this Hematologic Oncology Update episode published?

This episode was published on May 16, 2025.

Can I download this Hematologic Oncology Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!